The Pentagon isn’t able to tell federal auditors what happened to more than $1.3 billion in funds intended for construction projects in Afghanistan.
The money was dispersed through a program established to speed up the rebuilding process in Afghanistan by giving money directly to military officers to build roads, bridges, dams and other projects to avoid the lengthy bureaucratic procurement process.
But in the rush to spend and build, much of the money paid out by the Commander’s Emergency Response Program (CERP) between 2004 and 2014 has gone unaccounted for, according to auditors who spent the last year trying to find it.
A new report released Friday by the Special Inspector General for Afghanistan Reconstruction says the Defense Department could only provide its office with documentation for $890 million, or roughly 40 percent, of the total $2.2 billion in funds.
The auditors blamed the Pentagon’s financial and project management process for not sufficiently tracking spending, saying DoD’s system doesn’t contain enough data or comprehensive information relating to the actual costs of the projects.
The auditors took the information the Pentagon did provide and divided it up into categories like education, health care, water and sanitation. Aside from transportation, the item that had the most expenses was labeled “unknown.”
U.S. Central Command responded to the inspector general’s findings, or lack thereof, by saying that some of the unaccounted for CERP funds had been shifted to other military needs. “Although the report is technically accurate, it did not discuss the counterinsurgency strategies in relationship to CERP,” the Central Command said.
In total, the U.S. has doled out about $3.7 billion through CERP funds, with $2.2 billion coming from the Defense Department.
This is just the latest report from SIGAR highlighting the Pentagon’s problems keeping track of the enormous amount of money flowing into Afghanistan. Earlier reporting suggested the U.S. has lost some $100 billion in the reconstruction efforts.
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.